Weight Management: Improved metabolism and blood sugar regulation help patients overcome weight plateaus and improve body composition
The approved dose for this indication is 2.4 mg, administered through a once-weekly injection
Like other GLP-1 medications, Mounjaro has been prescribed to both diabetes patients and weight loss patients, but lawsuits claim that many suffered severe side effects, including delayed gastric emptying, bowel obstruction, cyclic vomiting syndrome, and even permanent vision loss
For more details, please refer to the manual: Handling and Storage of Synthetic Peptides References Khavinson VKh, Bondarev IE, Butyugov AA
Some patients prefer nighttime administration for practical reasons